Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| LLY | Eli Lilly & Co. | 0.13% | 365.73 | 1.1% | $1198.66m | |
| JNJ | Johnson & Johnson | 0.02% | 177.27 | 0.7% | $1105.44m | |
| MRK | Merck & Co., Inc. | 0.87% | 108.43 | 0.7% | $979.75m | |
| PFE | Pfizer Inc. | 0.78% | 49.60 | 0.9% | $971.15m | |
| ABBV | AbbVie, Inc. | -0.80% | 158.34 | 1.9% | $838.84m | |
| BMY | Bristol-Myers Squibb Co. | -0.13% | 79.14 | 1.1% | $734.71m | |
| AZN | AstraZeneca Plc | 0.06% | 66.21 | 1.0% | $359.51m | |
| IDXX | IDEXX Laboratories, Inc. | -2.74% | 400.10 | 3.9% | $216.62m | |
| CTLT | Catalent, Inc. | 13.32% | 46.91 | 1.9% | $200.95m | |
| GSK | GSK Plc | -0.65% | 33.77 | 0.3% | $199.83m | |
| HZNP | Horizon Therapeutics Plc | -0.36% | 78.00 | 5.4% | $196.93m | |
| NVS | Novartis AG | -0.04% | 87.68 | 0.2% | $186.54m | |
| NVO | Novo Nordisk A/S | 2.08% | 121.27 | 0.1% | $162.88m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | -1.66% | 209.20 | 8.0% | $139.45m | |
| VTRS | Viatris, Inc. | -0.72% | 11.06 | 0.0% | $119.33m |
Company Profile
BioLineRx Ltd. is a clinical stage biopharmaceutical company, which focuses on oncology. Its pipeline includes Motaxafortide (BL-8040), which is used for stem-cell mobilization, solid tumors, and acute myeloid lukemia; and AGI-134, which is a immunotherapy treatment used fro multiple solid tumors. The company was founded in 2003 and is headquartered in Modi'in, Israel.